| Literature DB >> 32187990 |
Shuangqi Fan1,2, Keke Wu1,2, Mengpo Zhao1,2, Erpeng Zhu1,2, Shengming Ma1,2, Yuming Chen1,2, Hongxing Ding1,2, Lin Yi1,2, Mingqiu Zhao1,2, Jinding Chen1,2.
Abstract
Autophagy is a general protective mechanism for maintaining homeostasis in eukaryotic cells, regulating cellular metabolism, and promoting cell survival by degrading and recycling cellular components under stress conditions. The degradation pathway that is mediated by autophagy receptors is called selective autophagy, also named as xenophagy. Autophagy receptor NDP52 acts as a 'bridge' between autophagy and the ubiquitin-proteasome system, and it also plays an important role in the process of selective autophagy. Pathogenic microbial infections cause various diseases in both humans and animals, posing a great threat to public health. Increasing evidence has revealed that autophagy and autophagy receptors are involved in the life cycle of pathogenic microbial infections. The interaction between autophagy receptor and pathogenic microorganism not only affects the replication of these microorganisms in the host cell, but it also affects the host's immune system. This review aims to discuss the effects of autophagy on pathogenic microbial infection and replication, and summarizes the mechanisms by which autophagy receptors interact with microorganisms. While considering the role of autophagy receptors in microbial infection, NDP52 might be a potential target for developing effective therapies to treat pathogenic microbial infections.Entities:
Keywords: NDP52; autophagy; autophagy receptor; microbial infection; ubiquitin-proteasome
Mesh:
Substances:
Year: 2020 PMID: 32187990 PMCID: PMC7139735 DOI: 10.3390/ijms21062008
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1The autophagic process. Autophagy proceeds through at least five discrete steps: initiation, membrane nucleation and phagophore formation, phagophore elongation, lysosome fusion, and degradation. These steps are controlled by at least five different functional groups of proteins: ATG1/Ulk1 initiation complex, class III PtdIns 3-kinase nucleation complex, PtdIns3P-binding complex, conjugation system, and degradation [7] (Arrow shape indicates next step).
Figure 2Structure-function of NDP52. NDP52 contains 446 amino acid (aa), including the domains of SKICH, LC3-interaction region (LIR), COILED-COIL, GALB1, and UBZ. UBZ domain interacts with Ub, identifies and binds autophagy substrates. LIR domain interacts with LC3 and assists substrate anchoring to autophagosome membranes. GALB1 domain interacts with GAL8 (modified from reference [30]).
Function of autophagy and NDP52 in bacterial infections.
| Function of Autophagy and NDP52 in Bacterial Infections | ||||
|---|---|---|---|---|
| Bacteria | Induction/Inhibition Autophagy | Autophagy in Bacterial Infections | NDP52 in Bacterial Infections | Reference |
|
| Induction | Inhibition | NDP52 binds | [ |
|
| Induction | Inhibition | NDP52 targets | [ |
|
| Induction | Inhibition | NDP52 targets the | [ |
|
| Inhibition (M protein) | Inhibition | NDP52 binds the | [ |
Figure 3Dual role of NDP52 in Salmonella infection. Salmonella colonizes within Salmonella-containing vesicles (SCV) and replicates itself. After the vesicles burst, they are released into the cytoplasm and reproduce in large numbers. NDP52 identify and target Salmonella that are released into the cytoplasm through its UBZ domain and LC3c binding site (CLIR motif), and, independently, regulates autophagosome maturation through its LC3a, LC3b, or Gabarapl2 binding site (LIR-like motif) and its Myo6 interacting region (modified from [37]).
Function of autophagy and NDP52 in virus infections.
| Function of Autophagy and NDP52 in Virus Infections | ||||
|---|---|---|---|---|
| Virus | Induction/Inhibition Autophagy | Autophagy in Virus Infections | NDP52 in Virus Infections | Reference |
| CSFV | Induction | Promotes CSFV replication | NDP52 interacts with E2 protein | [ |
| MeV | Induction | Promotes Mev replication | NDP52 interacts with MeV-C and MeV-V protein | [ |
| CVB3 | Induction | Promotes CVB3 replication | NDP52 interacts withVP1, promoting the ubiquitination of VP1 protein | [ |
| CHIV | Induction | Promotes CHIV replication | NDP52 interacts withVP1, reducing CHIV infection | [ |
| Influenza Virus | Induction | Promotes Influenza Virus replication | PB1-F2 interacts with NDP52 | [ |
| HSV1 | Inhibition | Restricts HSV1 replication | HSV1 removes NDP52 from the nucleus | [ |
Figure 4The mechanism of NDP52 in CSFV infections. In the CSFV infection PK-15 cells, NDP52 protein co-localized with CSFV E2 protein in the cytoplasm. Inhibition of NDP52 reduces the binding of E2 protein and lysosomal marker molecule CD63. The inhibition of NDP52 promotes the activation of the NF-κB signaling pathway and promotes the release of cytokines such as IFNα, inhibiting CSFV replication (Arrow shape indicates next step, T shape indicates suppression).